A protein known to be overly active in breast cancer can exist in a form that seems to change the structural composition of mammary tissue, potentially making it more conducive to tumor progression, say researchers from the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center

Aggressive, deadly and often misdiagnosed, inflammatory breast cancer (IBC) is the most lethal form of primary breast cancer, often striking women in their prime and causing death within 18 to 24 months. Now, scientists from The Cancer Institute at NYU Langone Medical Center have identified a key ge

Abraxis Bioscience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, has now made ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) (nab-paclitaxel) available in China for the treatment of patients with metastatic b

Fear plays a major role in whether women decide to go for cancer screening or not, but healthcare providers underestimate how much women need to know and wrongly assume that they will ask for information if they want it. Those are the two key findings from a study published in the June issue of th

Testing for genetic mutations can help identify breast cancer patients who do not benefit from a certain type of chemotherapy, according to a study published Tuesday in the journal Clinical Cancer Research, Reuters reports. The study included 588 breast cancer patients in the U.S. and Norway. Some o

Researchers have found links between an individual's genetics and their response to treatment with chemotherapy. The findings, by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and colleagues, show how a genetic variation, located in the SOD2 gene, may

High-quality one-stop breast clinics could be the most effective way to spot breast cancer early, a study published in the British Journal of Cancer * reveals today (Wednesday). Women going to their GP with symptoms that could be a sign of breast cancer are either referred to a one-stop clinic or

The UK's first guide to help secondary breast cancer1 patients struggling to access necessary levels of support and care has been launched today. Research from Breast Cancer Care has shown that almost 50 per cent of secondary breast cancer patients were not offered information on vital emotional an

Vanderbilt-Ingram Cancer Center researchers have uncovered a gene signature that may help predict clinical outcomes in certain types of breast cancer. In the Journal of Clinical Investigation, Harold (Hal) Moses, M.D., and colleagues report that this gene signature - which is associated with the tr

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its fully owned subsidiary, BiPar Sciences, today announced results from a randomized Phase 2 clinical trial of BSI-201, a poly ADP-ribose polymerase (PARP) inhibitor, in combination with gemcitabine and carboplatin (GC) chemotherapy, in patients with